Vaccination with Live Yersinia pestis Primes CD4 and CD8 T Cells That Synergistically Protect against Lethal Pulmonary Y. pestis Infection
- 1 February 2007
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 75 (2) , 878-885
- https://doi.org/10.1128/iai.01529-06
Abstract
Vaccination with live attenuated Yersinia pestis confers protection against pneumonic plague but is not considered safe for general use. Subunit plague vaccines containing the Y. pestis F1 and LcrV proteins prime robust antibody responses but may not provide sufficient protection. To aid the development of a safe and effective plague vaccine, we are investigating roles for T cells during defense against Y. pestis infection. Here we demonstrate that vaccination of mice with live Y. pestis primes specific CD4 and CD8 T cells that, upon purification and direct transfer to naïve mice, synergistically protect against lethal intranasal Y. pestis challenge. While not preventing extrapulmonary dissemination, the coadministered T cells promote bacterial clearance and reduce bacteremia. These observations strongly suggest that development of pneumonic plague vaccines should strive to prime both CD4 and CD8 T cells. Finally, we demonstrate that vaccination with live Y. pestis primes CD4 and CD8 T cells that respond to Y. pestis strains lacking the capacity to express F1, LcrV, and all pCD1/pPCP-encoded proteins, suggesting that protective T cells likely recognize antigens distinct from those previously defined as targets for humoral immunity.Keywords
This publication has 57 references indexed in Scilit:
- Gamma Interferon, Tumor Necrosis Factor Alpha, and Nitric Oxide Synthase 2, Key Elements of Cellular Immunity, Perform Critical Protective Functions during Humoral Defense against Lethal PulmonaryYersinia pestisInfectionInfection and Immunity, 2006
- The Anti-Plague System and the Soviet Biological Warfare ProgramCritical Reviews in Microbiology, 2006
- Cell-Mediated Protection against PulmonaryYersinia pestisInfectionInfection and Immunity, 2005
- The adaptor molecules LAT and SLP-76 are specifically targeted by Yersinia to inhibit T cell activationThe Journal of Experimental Medicine, 2005
- Yersinia pestis (plague) vaccinesExpert Opinion on Biological Therapy, 2004
- Intraspecific Diversity ofYersinia pestisClinical Microbiology Reviews, 2004
- Interleukin-10 and Inhibition of Innate Immunity to Yersiniae: Roles of Yops and LcrV (V Antigen)Infection and Immunity, 2003
- Multidrug Resistance inYersinia pestisMediated by a Transferable PlasmidNew England Journal of Medicine, 1997
- Cellular Immune Response to Yersinia pestis Modulated by Product (s) from Thymus-Derived LymphocytesThe Journal of Infectious Diseases, 1977
- Plague Immunization. I. Past and Present TrendsThe Journal of Infectious Diseases, 1974